Charles M. Perou

250.3k citations
512 papers · 82.8k indexed · 31 hit papers · h-index 112

Impact in

  • Cancer Research top 0.01%
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.01%
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis
    • Cancer-related Molecular Pathways

Papers in

    • Breast Cancer Treatment Studies 129
    • Cancer Genomics and Diagnostics 111
    • HER2/EGFR in Cancer Research 87
    • Cancer Cells and Metastasis 83
    • Cancer-related Molecular Pathways 44

Charles M. Perou

472 papers receiving 81.0k citations

Hit Papers

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update 2020 · 851 citations
851199920262008201710002.0k3.0k

Peers

Charles M. Perou
Comparison fields: 5 of 197
  • Cancer Research 39.3k
  • Oncology 39.5k
  • Molecular Biology 40.5k
  • Pathology and Forensic Medicine 9.0k
  • Genetics 11.3k
Replace Gabriel N. Hortobágyi with:
Gabriel N. Hortobágyi United States
Ian O. Ellis United Kingdom
Adrian L. Harris United Kingdom
Kenneth W. Kinzler United States
Giuseppe Viale Italy
Matt van de Rijn United States
Todd R. Golub United States
Tyler Jacks United States
Gordon B. Mills United States
Ralph H. Hruban United States
Charles M. Perou relative to Gabriel N. Hortobágyi United States Gabriel N. Hortobágyi's profile →
Citations per field
00.5×1.5×1.8×
Gabriel N. Hortobágyi · 1×
Citations per year

Countries citing papers authored by Charles M. Perou

Since Specialization
Citations

This map shows the geographic impact of Charles M. Perou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Perou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Perou more than expected).

Fields of papers citing papers by Charles M. Perou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles M. Perou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Perou. The network helps show where Charles M. Perou may publish in the future.

Co-authors

The 25 scholars most cited alongside Charles M. Perou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles M. Perou Line = papers co-authored together Charles M. Perou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20247
2 202049
3 202014
4 2019140
5 201710
6 201734
7 201554
8 2014194
9 201485
10 201433
11
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
Hit paper breakdown →
2014650
12 201278
13
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Hit paper breakdown →
2010542
14 201040
15 2009174
16 2009100
17 2009345
18
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Hit paper breakdown →
20051414
19 2004143
20
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
Hit paper breakdown →
19991087

About Charles M. Perou

Charles M. Perou is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 512 papers that have together received 82.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (129 papers), Cancer Genomics and Diagnostics (111 papers), HER2/EGFR in Cancer Research (87 papers), Gene expression and cancer classification (83 papers), Cancer Cells and Metastasis (83 papers), Molecular Biology Techniques and Applications (45 papers), Cancer-related Molecular Pathways (44 papers) and Advanced Breast Cancer Therapies (42 papers). The work is most often cited by research in Cancer Research (39.3k citations), Oncology (39.5k citations), Molecular Biology (40.5k citations), Pathology and Forensic Medicine (9.0k citations) and Genetics (11.3k citations). Charles M. Perou has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include David Botstein, Patrick O. Brown, Matt van de Rijn, Joel S. Parker, Per Eystein Lønning, Stefanie S. Jeffrey, Thérese Sørlie, Michael B. Eisen, Hilde Johnsen and Aleix Prat. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Breast Cancer Research and Treatment and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026